|
|
19204 North Creek Parkway Suite #100
Bothell, WA 98011 USA
phone:(425) 368-1050
fax:(425) 368-1051
|
|
| Symbol |
DDD |
| Exchange |
AMEX |
| Founded |
1983 |
| Employees |
|
|
|
| www.scolr.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drug delivery focused on self-correcting oral linear release systems. |
|
| Management |
| Stephen J. Turner, President and Chief Executive Officer; Richard M. Levy, Chief Financial Officer and Vice President; Michael N. Taglich, Board of Directors; Randall L-W. Caudill, D.Phil., Board of Directors; Herbert L. Lucas, Board of Directors |
| |
|
|
|
|
|
|
|
| Keywords |
| rivastigmine, ibuprofen, risperidone, fenofibrate, pseudoephedrine |
|
|
|
| Description |
|
SCOLR Pharma, Inc. (SCOLR Pharma), formerly SCOLR, Inc., is a drug-delivery company that develops and formulates pharmaceutical, over-the-counter (OTC) and nutritional products using its controlled delivery technology. |
|
| Products / Services |
The Company's lead products include CDT ibuprofen, pseudoephedrine and raloxifene.
|
|
| Technology / Differentiation |
| SCOLR's technology has been used to develop dietary supplement products that are being manufactured and distributed by third parties. |
|
| Market / Customers |
DT Glucosamine and Chondroitin products are available nationwide in more than 8,000 retail outlets.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
